Findings may support development of more refined personalized breast cancer risk prediction models for BRCA1 pathogenic ...
Damaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast ...
Damaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast ...
Strongest association found for genes involved in natural killer cell activationFindings suggest need for more refined, ...
Damaging variants in genes involved in a rapid immune response (innate immunity) are significantly linked to earlier breast cancer onset in carriers ...
The whole-exome sequencing (WES) significantly improves diagnostic accuracy for monogenic foetal structural anomalies (FSAs), ...
Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
Genetic mutations found in the body’s immune response are “significantly associated” with earlier breast cancer onset among ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
A $4.7 million collaboration led by the National Cancer Centre Singapore will develop a clinical-grade test using AI and ...
Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related adverse events remain a major concern.
Tumor mutational burden, or TMB, has long been viewed as a promising way to identify which patients may benefit from cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results